Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency
Clinical trial NCT06199531 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06199531
- Sponsor
- Grace Science, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-13
- Primary completion
- 2027-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.